In a new paper, researchers from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine ('Insilico'), in collaboration with NVIDIA, present a new large language model (LLM) transformer for solving biological and chemical tasks called nach0.
May 20 2024Insilico Medicine In a new paper, researchers from clinical stage artificial intelligence -driven drug discovery company Insilico Medicine , in collaboration with NVIDIA, present a new large language model transformer for solving biological and chemical tasks called nach0.
Nach0 seeks to bridge this gap for the first time. It draws from a dataset that includes abstract texts extracted from PubMed and patent descriptions derived from the U.S. Patent and Trademark Office related to the chemistry domain – 100 million documents that became 355 million tokens worth of abstracts and 2.9 billion patents, as well as molecular structures using simplified molecular-input line-entry system .
Nach0 represents a step forward in automating drug discovery through natural language prompts. In the future, we foresee the potential inclusion of protein sequences with their own special tokens as well as fine-tuning the model in order to accommodate new modalities and exploring the fusion of information from text and knowledge graphs." Nach0 is built on the NVIDIA BioNeMo generative AI platform, enabling training and scaling of drug discovery applications.
Related StoriesMeasured against other LLMs used for biomedical understanding, such as FLAN, SciFive, and MolT5, nach0 was found to have distinct advantages when performing molecular tasks using molecular data, and it significantly outperformed ChatGPT.
Aging Artificial Intelligence Biotechnology Cancer Cell Cell Line Drug Discovery Drugs Fibrosis Genes Language Molecule Preclinical Research
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeuticClosed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced...
Read more »
The AI PC grudge match begins as Nvidia dismisses 'basic' AMD, Intel, Apple and Qualcomm NPUsJeremy has been writing about technology and PCs since the 90nm Netburst era (Google it!) and enjoys nothing more than a serious dissertation on the finer points of monitor input lag and overshoot followed by a forensic examination of advanced lithography. Or maybe he just likes machines that go “ping!” He also has a thing for tennis and cars.
Read more »
MSI Raider GE78 HX review: powerful gaming laptop but way too noisyWith top-quality Intel and NVIDIA parts, this MSI Raider laptop almost has it all.
Read more »
Nvidia RTX 4080 Super review: one of the fastest GPUs I've usedThinking of upgrading from a Nvidia 30 Series? This is the GPU you need.
Read more »
Banned Nvidia GPUs sneak into sanction-busting Chinese serversGraphics giant and partners say they're clean - it's all technically legit
Read more »
I tried Nvidia's AI for games, with comically realistic resultsIan Dean is Editor, Digital Arts & 3D at Creativebloq, and the former editor of many leading magazines. These titles included ImagineFX, 3D World and leading video game title Official PlayStation Magazine. In his early career he wrote for music and film magazines including Uncut and SFX. Ian launched Xbox magazine X360 and edited PlayStation World.
Read more »